A-HIPI
About
About the model: This model was developed from detailed individual patient data from a pooled cohort of 4,027 patients treated in eight seminal international advanced-stage classic Hodgkin lymphoma clinical trials, conducted from 1996-2019. The model performance was validated in a cohort of 1,431 patients from four large prospective classic Hodgkin lymphoma cohorts and registries.
DISCLAIMER: The content on the site is not medical advice. Although some content may be provided by medical professionals, users acknowledge that access or use of the content does not create a provider-patient relationship and does not constitute medical advice, treatment, diagnosis or services of any kind. The information is provided for educational purposes only and as such is not a substitute for professional medical attention and treatment by medical professionals. Users are solely responsible and accept all liability resulting from use of the content and any related services or products.
References
Rodday, Angie Mae. Parsons, Susan K. Upshaw, Jenica N. Friedberg, Jonathan W. Gallamini, Andrea. Hawkes, Eliza. Hodgson, David. Johnson, Peter. Link, Brian K. Mou, Eric. Savage, Kerry J. Zinzani, Pier Luigi. Maurer, Matthew. Evens, Andrew M.
By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.